Treatment of multiple sclerosis and other autoimmune...

Details Treatment of multiple sclerosis and other autoimmune... Treatment of multiple sclerosis and other autoimmune...

2011-06-28

2011-06-28

Ha, Julie (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S021900

Reexamination Certificate

active

07968516

ABSTRACT:
Described herein are compounds and methods for treating or preventing a neurologic, otologic, or ophthalmologic disease in a subject. Also described herein are compounds that can be used as therapeutics.

REFERENCES:
patent: 0279887 (1988-08-01), None
patent: 1454627 (2004-09-01), None
Di Rosa G, Odrljin T, Nixon RA, Arancio O, “Calpain Inhibitors,” Journal of Molecular Neuroscience, Oct. 2002, 19 (1-2): 135-141.
Neurological Degeneration from http://www.northshore.org/clinicalservices/medicalgenetics/hereditaryconditions/default.aspx?id=4423, pp. 1-2. Accessed Jul. 6, 2009.
Retinitis Pigmentosa from http://emedicine.medscape.com/article/1227488-overview, pp. 1-6. Accessed Jul. 6, 2009.
Cataracts from http://www.allaboutvision.com/conditions/cataracts.htm, pp. 1-3. Accessed Jul. 6, 2009.
What is Alzheimer's from http://alz.org/alzheimers—disease—what—is—alzheimers.asp, pp. 1-4. Accessed Jul. 6, 2009.
Huntington's Disease from http://www.ninds.nih.gov/disorders/huntington/huntington.htm, pp. 1-2. Accessed Jul. 6, 2009.
What is a stroke from http://www.stroke.org/site/PageServer?pagename=STROKE, pp. 1-2. Accessed Jul. 6, 2009.
Spinal Cord injury from http://www.faqs.org/health/Sick-V4/Spinal-Cord-Injury.html, pp. 1-6. Accessed Jul. 6, 2009.
Pepstatin structure from http://www.mpbio.com/product—info.php?products—id=195368, pp. 1-3. Accessed Jul. 6, 2009.
Chymostatin structure from http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/Product—Information—Sheet/c7268pis.Par.0001.File.tmp/c7268pis.pdf, pp. 1-2. Accessed Jul. 6, 2009.
Alzheimer disease from Merck manual, pp. 1-17. Accessed Jul. 29, 2009.
Mattson MP, “Pathways towards and away from Alzheimer's disease,” Nature, 2004, 430: 631-639.
Huntington's disease from Merck manual, pp. 1-2. Accessed Mar. 14, 2010.
Parkinson's disease from Merck manual, pp. 1-10. Accessed Mar. 14, 2010.
Multiple sclerosis from NIH, pp. 1-4. Accessed Mar. 14, 2010.
Steinman L, Zamvil SS, “How to successfully apply animal studies in experimental allerfic encephalomyelitis to research on multiple sclerosis,” Ann Neurol, 2006, 60: 12-21.
Sriram S, Steiner I, “Experimental allerfic encephalomyelitis: a misleading model of multiple sclerosis,” Ann Neurol, 2005, 58: 939-945.
Han H-K, “Targeted prodrug design to optimize drug delivery,” AAPS Pharmsci, 2000, 2(1): 1-11.

Affiliated with

Also associated with

Rating

Treatment of multiple sclerosis and other autoimmune... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of multiple sclerosis and other autoimmune..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of multiple sclerosis and other autoimmune... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2713892